Home › Studies › PRJNA524170
PRJNA524170 SRP186913

Pouchitis antibiotic therapy and gut microbiome, Tel-Aviv

Resistant microbiome underlies antibiotic therapy in pouchitis

Longitudinal study of 234 fecal samples from pouchitis/pouch patients in Tel-Aviv, Israel, examining gut microbiome changes associated with antibiotic (ciprofloxacin/metronidazole) treatment response and antibiotic dependence. machine-written summary

234 samples · 234 runs · IL · Age unknown · 2019 · 1.00 Gbp / sample

Sources
✓Sequence archive 1,404✓Abstract / description 139○Full text✓Supplementary tables 559–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,404 sample values (collection date, country, latitude, location locality, location region, longitude)
✓ Abstract / description139 sample values (health condition detail)
○ Full textread; no usable statement or table · PMC8546988
✓ Supplementary tables559 sample values (age, health condition, health condition detail, sex, subject id)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
unknown111
adult102
elderly21
Condition
healthy_control39
ibd_unspecified35
colorectal_adenoma21
Sex
female73
male50
Country
IL234
Body site
primary234
Collected 2010–2016
2010: 7 samples2011: 65 samples2012: 27 samples2013: 41 samples2014: 33 samples2015: 28 samples2016: 33 samples20102016
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 120 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 114 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 1.00 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

32 of 40 people sampled more than once (115 samples; median 3, up to 12 per person) · follow-up median 2.2 y (max 5.8 y) · median interval between samples 8 mo (time from age at collection). Schedule stated by the source: “Fecal samples (n=234) collected over time during or absent antibiotic treatment; 40 subjects, median 3 samples/subject (max 12)”.

po1po1: day 0po1: day 182po11po11: day 0po11: day 213po11: day 396po12po12: day 0po12: day 517po14po14: day 0po14: day 730po14: day 1126po14: day 1491po15po15: day 0po15: day 335po15: day 396po15: day 731po15: day 1126po16po16: day 0po16: day 152po16: day 548po16: day 730po16: day 1096po16: day 1217po17po17: day 0po17: day 213po17: day 395po18po18: day 0po18: day 274po18: day 456po18: day 1004po19po19: day 0po19: day 91po19: day 274po19: day 2130po2po2: day 0po2: day 700po2: day 882po21po21: day 0po21: day 183po21: day 853po21: day 1553po23po23: day 0po23: day 334po24po24: day 0po24: day 121po24: day 304po25po25: day 0po25: day 365po26po26: day 0po26: day 152po26: day 335po26: day 1187po27po27: day 0po27: day 1156po27: day 1369po3po3: day 0po3: day 487po3: day 1370po3: day 1583po3: day 1857po30po30: day 0po30: day 243po30: day 335po30: day 456po30: day 791po30: day 1826po30: day 1856po30: day 1887po30: day 1948po30: day 2009po30: day 2100po30: day 2130po31po31: day 0po31: day 548po34po34: day 0po34: day 61po34: day 243po35po35: day 0po35: day 152po35: day 304po35: day 548po35: day 639po35: day 1309po35: day 1552po37po37: day 0po37: day 213po39po39: day 0po39: day 122po39: day 1096po4po4: day 0po4: day 396po40po40: day 0po40: day 91po40: day 974po40: day 1126po40: day 1522po40: day 1796po40: day 2131po42po42: day 0po42: day 152po42: day 396po45po45: day 0po45: day 335po45: day 1796po47po47: day 0po47: day 730po48po48: day 0po48: day 396po5po5: day 0po5: day 639po5: day 852po6po6: day 0po6: day 334po6: day 730po7po7: day 0po7: day 1210 d18 mo2.9 y4.4 y5.8 y

Each row is one person (32 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Streptococcus 22.2%Escherichia 15.4%Bifidobacterium 8.2%Blautia_A 7.4%Mediterraneibacter 4.2%Phocaeicola 2.7%Veillonella 2.2%Faecalibacterium 1.8%Anaerostipes 1.6%Faecalimonas 1.5%Enterococcus_B 1.5%Lactobacillus 1.5%not assigned to a genus 6.5%other genera 23.4%

Genera, mean relative abundance over 101 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category123 53%
country234 100%234
health_condition95 41%95
subject_id123 53%123
collection_date234 100%234
detailed_location234 100%
health_condition_detail234 100%95139
latitude234 100%234
location_locality234 100%234
location_region234 100%234
longitude234 100%234
age_at_collection_days123 53%123
sex123 53%123
Papers (2)
  • Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy. 2020 PMID 31605691 own_data
  • Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease. 2021 PMID 33653942 PMC8546988 unsure
Details
Archive description

Pouchitis developing after total proctocolectomy and ileal pouch anal anastomosis in patients with ulcerative colitis is usually treated with antibiotics. Patients often develop antibiotic dependent or refractory disease and may be treated with antibiotics for prolonged periods. The mechanisms of response to antibiotic treatment in pouchitis and the effects on bacterial communities are mostly unknown. In this study we investigated the microbial factors that underlie the response to antibiotic treatment for pouchitis and why patients tend to develop antibiotic dependence.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.80. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site run.scientific_name · “feces metagenome”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN11023869age_at_collection_days25020.0R20.85paper.supp.msystems.00984-20-sd001.xlsx[Data Set S1-sheet1 - Metadata for Pouch patients cohort (discovery)!Age (relative to sample)]L7: Age (relative to sample)=68.5
SAMN11023868collection_date2013-01-10R10.90biosample.attribute:collection_date2013-01-10
SAMN11023868countryILR10.90sample.attr.geo_loc_nameIsrael: Tel-Aviv
SAMN11023869health_conditionhealthy_controlR20.85paper.supp.msystems.00984-20-sd001.xlsx[Data Set S1-sheet1 - Metadata for Pouch patients cohort (discovery)!Pouch_phenotype (disease behavior)]L7: Pouch_phenotype (disease behavior)=Normal pouch
SAMN11023869health_condition_detailPouch_phenotype (disease behavior): Normal pouchR20.85paper.supp.msystems.00984-20-sd001.xlsx[Data Set S1-sheet1 - Metadata for Pouch patients cohort (discovery)!Pouch_phenotype (disease behavior)]L7: Pouch_phenotype (disease behavior)=Normal pouch
SAMN11023868health_condition_detailmixed_case_control: pouchitis patients (recurrent-acute, chronic, Crohn's-like) vs normal pouch controlsR40.50study.descriptionPouchitis developing after total proctocolectomy
SAMN11023868latitude32.0806R10.90biosample.attribute:lat_lon32.0806 N 34.7898 E
SAMN11023868location_localityTel AvivR10.75biosample.attribute:geo_loc_nameIsrael: Tel-Aviv
SAMN11023868location_regionTel AvivR10.60biosample.attribute:lat_lon32.0806 N 34.7898 E
SAMN11023868longitude34.7898R10.90biosample.attribute:lat_lon32.0806 N 34.7898 E
SAMN11023869sexfemaleR20.85paper.supp.msystems.00984-20-sd001.xlsx[Data Set S1-sheet1 - Metadata for Pouch patients cohort (discovery)!Gender]L7: Gender=Female
SAMN11023869subject_idpo58R20.85paper.supp.msystems.00984-20-sd001.xlsx[Data Set S1-sheet1 - Metadata for Pouch patients cohort (discovery)!Patient_ID]L7: Patient_ID=po58
Sequencing

234 runs over 234 samples · mean 0.99 Gbp per run (median 1.00 Gbp, total 232.22 Gbp; 234 runs with a base count) · layout PAIRED 234 · platform ILLUMINA 234 · models NextSeq 500 (234) · 44% of runs with a Sandpiper profile · first public 2019-10-22

Authors (20)

Dubinsky V first · Reshef L · Bar N · Keizer D · Golan N · Rabinowitz K · Godny L · Yadgar K · Zonensain K · Tulchinsky H · Gophna U · Dotan I last · Wasserberg N · Rozman V first · Mohar Lorbeg P · Treven P · Accetto T · Golob M · Zdovc I · Bogovič Matijašić B last

Downloads

PRJNA524170.csv.gz (8.6 KB) · parquet (82.4 KB) — all 234 samples, every field with route and confidence · PRJNA524170_determinations.csv.gz (21.1 KB) — 2,102 evidence rows

Samples (234 · every field this project has values for · hover a cell for its source)
Loading the sample table…